Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016826
Chunk: 101

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 101
---
) | Paragraphs (1)(i) and (1)(ii) of this section do not apply if the registration statement is on Form S-8,                                      
 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished 
 to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))  
 that are incorporated by reference in the registration statement; and                                                                         |

| (B) | Paragraphs (1)(i), (a)(1)(ii) and (1)(iii) of this section do not apply if the registration statement                                     
 is on Form S-3 or Form F-3 and the information required to be included in a post-effective amendment by those paragraphs is contained     
 in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange 
 Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to   
 Rule 424(b) that is part of the registration statement.                                                                                   |

| (C) | Provided further, however, that paragraphs (1)(i) and (1)(ii) do not apply if the registration statement                               
 is for an offering of asset-backed securities on Form S-1 or Form S-3, and the information required to be included in a post-effective 
 amendment is provided pursuant to Item 1100(c) of Regulation.                                                                          |

| (2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective                                        
 amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities 
 at that time shall be deemed to be the initial bona fide offering thereof.                                                                   |

| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered 
 which remain unsold at the termination of the offering.                                                   |

| 53 |

| (4) | To file a post-effective amendment to the registration statement to include any financial statements required                              
 by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information   
 otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes